https://www.england.nhs.uk/commissioning/spec-services/key-docs/<\/a><\/p> <\/p>
The Methods sets out the process for completing service specification work and, in accordance with this process, the Specialised Cancer Surgery CRG has been asked to consider progressing this work. The CRG Chair is due to discuss the matter with a representative of the Gynaecology CRG later this week and, following this, it is expected that the first step of the process will be completed by the middle of March 2017.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4080", "label" : {"_value" : "Biography information for David Mowat"}
}
, "answeringMemberConstituency" : {"_value" : "Warrington South"}
, "answeringMemberPrinted" : {"_value" : "David Mowat"}
, "dateOfAnswer" : {"_value" : "2017-03-02", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-03-02T11:10:35.533Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-02-27", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Ovarian Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, when NHS England plans to publish its service specification on ovarian cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1581", "label" : {"_value" : "Biography information for Mr Peter Bone"}
}
, "tablingMemberConstituency" : {"_value" : "Wellingborough"}
, "tablingMemberPrinted" : [{"_value" : "Mr Peter Bone"}
], "uin" : "65673"}
, {"_about" : "http://data.parliament.uk/resources/178159", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/178159/answer", "answerText" : {"_value" : "
For each Be Clear on Cancer campaign there is a comprehensive evaluation process. Data is collected on a number of metrics to reflect the possible campaign impact on key elements of the patient pathway. Metrics evaluated include survival rates, indicators for earlier diagnosis and general awareness of ovarian cancer symptoms.<\/p>
<\/p>
<\/p>
<\/p>
For the regional ovarian pilot in the North West, we have so far been able to look at the following metrics:<\/p>
<\/p>
- cancer awareness levels;<\/p>
<\/p>
- urgent general practitioner (GP) (two week wait) referrals for suspected gynaecological cancers;<\/p>
<\/p>
- ovarian cancers diagnosed following a two week wait referral;<\/p>
<\/p>
- all ovarian cancers diagnosed and recorded in the cancer waiting times database;<\/p>
<\/p>
- conversion rate (percentage of two week wait referrals resulting in a cancer diagnosis); and<\/p>
<\/p>
- detection rate (percentage of Cancer Waiting Times (CWT) recorded cancers resulting from a two week wait referral).<\/p>
<\/p>
<\/p>
<\/p>
Some of the information required to fully evaluate campaigns takes longer to collate and analyse but gradually over time, when combined together, the metrics we analyse build up a detailed picture of potential campaign effects. This will include analysis of the following data:<\/p>
<\/p>
- GP attendances;<\/p>
<\/p>
- diagnostic tests, including CA125;<\/p>
<\/p>
- numbers of cancers recorded by the National Cancer Registration Service;<\/p>
<\/p>
- stage at diagnosis; and<\/p>
<\/p>
- one year survival.<\/p>
<\/p>
<\/strong><\/p> <\/p>
The National Cancer Intelligence Network (part of Public Health England) have confirmed that they will publish a full and final evaluation report for the regional ovarian cancer pilot campaign as soon as possible, when analysis of all metrics is complete. However, in advance of a final evaluation report, they aim to publish an interim report containing the cancer awareness levels and the results from the analysis of CWT data before the end of February 2015, at which time we will share these results with the ovarian cancer expert group and ovarian cancer charities.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-02-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-02-10T16:09:39.273Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-02-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Ovarian Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the effect of the Be Clear on Cancer regional pilot in ovarian cancer on (a) survival rates, (b) early diagnosis and (c) general awareness of ovarian cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4032", "label" : {"_value" : "Biography information for Stuart Andrew"}
}
, "tablingMemberConstituency" : {"_value" : "Pudsey"}
, "tablingMemberPrinted" : [{"_value" : "Stuart Andrew"}
], "uin" : "223596"}
, {"_about" : "http://data.parliament.uk/resources/177186", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/177186/answer", "answerText" : {"_value" : "
For each Be Clear on Cancer campaign there is a comprehensive evaluation process. Data is collected on a number of metrics to reflect the possible campaign impact on key elements of the patient pathway.<\/p>
<\/p>
<\/p>
<\/p>
The National Cancer Intelligence Network (part of Public Health England) have confirmed that they will publish a full and final evaluation report for the regional ovarian cancer pilot campaign as soon as possible, when analysis of all metrics is complete. However, in advance of a final evaluation report, they aim to publish an interim report containing the cancer awareness levels and the results from the analysis of Cancer Waiting Times data before the end of February 2015, at which time we will arrange a meeting with Public Health England and ovarian cancer charities to discuss these results.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2015-02-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-02-05T17:49:22.727Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-02-02", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Ovarian Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, if he will meet bodies representing cancer sufferers to discuss the evaluation of the Be Clear on Cancer regional pilot for ovarian cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4032", "label" : {"_value" : "Biography information for Stuart Andrew"}
}
, "tablingMemberConstituency" : {"_value" : "Pudsey"}
, "tablingMemberPrinted" : [{"_value" : "Stuart Andrew"}
], "uin" : "222849"}
, {"_about" : "http://data.parliament.uk/resources/155937", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/155937/answer", "answerText" : {"_value" : "
The National Institute for Health and Care Excellence\u2019s clinical guideline on familial breast cancer, published in June 2013, recommends that women with breast or ovarian cancer should be offered genetic testing if their combined BRCA1 and BRCA2 mutation carrier possibility is 10% or more.<\/p>
<\/p>
<\/p>
<\/p>
NHS England is considering moving to a lower threshold as part of the annual prioritisation process for funding in 2015-16.<\/p>
<\/p>
<\/strong><\/p> <\/p>
We intend to raise the matter of genetic testing for ovarian cancer patients with the Health Ministers of Scotland, Wales, and Northern Ireland in our next regular meeting with them.<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-11-20", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "214783"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-11-20T16:50:39.107Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Ovarian Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the effectiveness of the implementation of the National Institute for Health and Care Excellence's most recent guidelines for genetic testing for ovarian cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4130", "label" : {"_value" : "Biography information for Baroness Ritchie of Downpatrick"}
}
, "tablingMemberConstituency" : {"_value" : "South Down"}
, "tablingMemberPrinted" : [{"_value" : "Ms Margaret Ritchie"}
], "uin" : "214812"}
, {"_about" : "http://data.parliament.uk/resources/100023", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100023/answer", "answerText" : {"_value" : "
We are investing £450 million in earlier diagnosis of cancer, including improving direct general practitioner access to non-obstetric ultrasound to support earlier diagnosis of ovarian cancer.<\/p>
<\/p>
<\/p>
<\/p>
Public Health England ran a regional Be Clear on Cancer campaign early in 2014 to raise awareness of the symptoms of ovarian cancer. The findings of the pilot will be evaluated in 2015, and this evidence would inform any decision to move from a regional to national campaign.<\/p>
<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-21T15:46:38.09492Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Ovarian Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps he is taking to increase early identification of ovarian cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1521", "label" : {"_value" : "Biography information for Mrs Sharon Hodgson"}
}
, "tablingMemberConstituency" : {"_value" : "Washington and Sunderland West"}
, "tablingMemberPrinted" : [{"_value" : "Mrs Sharon Hodgson"}
], "uin" : "905561"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 7, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}